Ligand Pharma (LGND) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $262.17 --0%
EPS Growth %: +25.6%
Financial Fact:
Total other income (expense), net: -4.26M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: +25.6%
Financial Fact:
Total other income (expense), net: -4.26M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $21.6 million versus the consensus estimate of $23.13 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Robinhood prices $2B convertible notes offering due 2029
- Ligand prices $625M convertible notes due 2031 at 0% interest
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
